Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

China flag China · Delayed Price · Currency is CNY
19.64
+0.16 (0.82%)
Apr 29, 2026, 3:00 PM CST
42.11%
Market Cap 2.39B
Revenue (ttm) 211.75M
Net Income (ttm) 17.62M
Shares Out 121.78M
EPS (ttm) 0.14
PE Ratio 135.73
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,981,414
Average Volume 2,533,244
Open 19.40
Previous Close 19.48
Day's Range 19.21 - 19.69
52-Week Range 12.14 - 23.44
Beta 0.19
RSI 45.81
Earnings Date Apr 18, 2026

About SHA:600671

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, hard capsules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, Chinese herbal medicine... [Read more]

Sector Healthcare
Founded 1958
Employees 362
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600671
Full Company Profile

Financial Performance

In 2025, SHA:600671's revenue was 211.75 million, a decrease of -2.55% compared to the previous year's 217.30 million. Earnings were 17.62 million, an increase of 15.59%.

Financial Statements

News

There is no news available yet.